KA-EX® is a patent-pending dietary supplement for recovery after intense sports or a night of partying.
In a few years only, KA-EX® has established itself as a top 10 best-selling dietary supplement in Switzerland. As the world's scientifically most advanced, holistic health booster, KA-EX® became an official supplier to some of the leading Swiss and German Football clubs, a Formula 1 Team, and over 1000 professional athletes.
KA-EX® is now launching a new «KA-EX® GO» version, and with the expansion to the USA, our exponential growth continues now.
- Strong Proof of Market Switzerland: Bestselling dietary supplement in Switzerland with almost twice the annual revenue of «Berocca Boost» (source: NIELSEN and IQVIA) and other global brands. Available at all Swiss pharmacies, Coop, Coop Pronto, Migros, and many more.
- Successful Launch in Germany: 938% sales growth from Q2 20201 to Q3 2021, and 694% from Q3 to Q4 2021
- Global Patent Application: Protection until 2037
- Scalable Ambassador Strategy: KA-EX® is the official recovery drink of a Formula 1 Team, the leading German and Swiss football clubs (FC Basel, FC Zürich, Union Berlin, and more), and +1000 world-class athletes who promote KA-EX® in return for free goods.
- Health-Positive: KA-EX® mitigates fatigue and improves physical and mental well-being naturally and genuinely, in contrast to high-caffeine/high-sugar energy drinks
- Internationalization: Market entry in the UK, France, and Spain in June 2022 and the USA in Q4 2022 -> Ready to market scale.
- Global Scalability in Operations: World's largest contract manufacturer with global, high-volume operations. We are ready to supply a global mainstream demand.
- Attention - Last Call: This Conda campaign is expected to be the very last opportunity for private individuals to invest.
Martin Krüger, Athletics coach at 1. FC Union Berlin
«We use KA-EX® because it is a top-notch product. In the “English weeks,” when recovery is very important, we made it mandatory for the players. It totally helped us in the games. It is just a very great product that helped us a lot.”
Tobias Reichmuth, Entrepreneur and Investor «Höhle der Löwen» Switzerland
«I was thrilled that I could invest in the context of «Höhle der Löwen» and I think it was a very good investment. So, I'm looking forward to the further cooperation of KAEX®. »
Like many good stories, the KA-EX® tale starts with a wild party night:
The idea came to Pedro Schmidt (Founder & CEO) the morning after partying with friends when he went to a pharmacy to find a product that accelerated the body's recovery by «reloading» with natural ingredients that are required in the process. OTC painkillers that have been used for over 100 years to treat hangovers hide the symptoms but do not help the body with the damage in any way. Pedro was surprised not to find a single product that suited his purpose. So, without further ado, putting his degree in pharmaceutical sciences from ETH Zurich to the test, he set about developing a product himself.
After five years of research and product development, the KA-EX® formula was ready, and the scientific innovation was filed for patent worldwide.
Invest 10.000 CHF and receive 100 individualized packs of KA-EX®.
The Darling of Swiss Drugstores and Pharmacies
Since the Brand's launch in October 2017, KA-EX® has quickly become the darling of drugstores and pharmacies in Switzerland. Without a fancy marketing campaign but many word-of-mouth recommendations, our powder drink has become one of Switzerland's top 10-best-selling dietary supplements in only a few years. Thanks to the great success in pharmacies, KA-EX® launched in supermarkets like Coop, Coop Pronto, Migros, SPAR Express, Jelmoli, and many more. According to independent Sales data (NIELSEN, IQVIA), today, KA-EX® sells about +75% more boxes a year than BAYER's flagship dietary supplement, «Berocca Boost».
Launch of a World-Premier KA-EX® READY-TO-DRINK with patented Push-Cap-Technology.
Is KA-EX® on the doping list?
With the mainstream success of KA-EX®, athletes discovered the recovery benefits also after their workouts. From physical exertion, also athletes suffer from micro-inflammations, over-acidity from lactic acid, an elevated stress-hormone level, and low sleep quality. It was early 2020 when the first professional athlete approached our company asking if KA-EX® was banned from doping, as he had great experiences and plans to include it in his training routine. After verifying that it was not, more professional athletes started to use KA-EX®, and only a few months after, FC Zürich made it available to their players, later also FC Basel. Before we knew it, KA-EX® became the official recovery drink of several German Bundesliga-Clubs, Alfa-Romeo Sauber Formula 1 Team, and over 1000 professional athletes.
Reached the Goals from First Conda Campaign in 2022 - This is now the last
In April 2022, we were one of the first projects to raise with Conda, with the goal of kickstarting our expansion in Europe, the UK, and the USA. We managed to do so, and thanks to the Conda Investment, KA-EX® became available in several European countries and the UK in the summer of 2022. In November 2022, KA-EX® launched in the USA. As reported by the media, KA-EX® even became an official supplier of upcoming NFL stars in January 2023!
For the launch of our new «KA-EX® GO» Product, we need working capital to produce the next batch. Based on the excellent experience from last year's Conda Campaign, we decided to repeat the crowd-investment one last time.
Why is this the LAST opportunity to invest in KA-EX®?
We forecast to reach a crucial milestone in Q3 2023: The BREAK-EVEN-POINT.
In the last few years, we built up the necessary operational structure to scale exponentially. We managed to do so and now have the essential manufacturing capabilities, the Brand, and the manpower to create a global mainstream demand. Our business will turn profitable in a few months, meaning we will become «bankable». Future growth will be primarily funded by dilution-free debt capital - equity investments will only be raised in case of a very high strategic upside (for instance, distribution in a specific market). Therefore, this is the last chance for private investors to invest in KA-EX®.
Pedro Schmidt holds a master’s degree in Pharmaceutical Sciences and Management from ETH Zurich. After graduation, Pedro worked as Product Rollout Manager at Bristol-Myers Squibb and Teva Pharmaceuticals.
David Guntern has more than 20 years of advertising experience in large Swiss creative agencies (MRB, Werbeanstalt Zürich) and worked on high-profile campaigns (Heineken, Mazda, others). Before joining ph. AG, he founded a company specializing in E-marketing, whose clients include BMW.
William is the CEO of MAREIN AG, a distribution company with 80 employees, 30.000 different items and 40 years of business. William joined ph. AG in November 2016 as a Co-Founder. AG. As the main investor, MAREIN is responsible for all logistics and distribution of KA-EX® in Switzerland and the EU, offering ph. AG a fully scalable and cost-effective distribution network.
Matthias worked for 13 years as a CFO at Givaudan and as a Divisional CFO for Roche Vitamins during the takeover by DSM.
Mauro works as a senior private equity manager at Woodman Asset Management.
Andreas led Lindt's initial expansion in Australia, growing its sales from $0 to $85 million. Later, as CEO of North America, he was responsible for Lindt USA, Canada, and Ghirardelli (52% of Lindt's global business, i.e., $1.8 billion in sales, six factories, 5,850 employees)
Jan has previously built three global consumer health businesses from scratch and sold them to Omega Pharma (Perrigo) and Trimb Healthcare AB (Swedish OTC company).
Manuel is a founding partner of Artemon Capital Partners AG, which structures tailor-made financing solutions and places them with professional and institutional investors.
